{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:41:08Z","timestamp":1792651268572,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12891-016-1379-y","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T05:38:46Z","timestamp":1484804326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-6410","authenticated-orcid":false,"given":"Ryuta","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Alaa","family":"Terkawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimasa","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2106\/00004623-196547030-00023","volume":"47","author":"R Merle D'Aubign\u00e9","year":"1965","unstructured":"Merle D'Aubign\u00e9 R, Postel M, Mazabraud A, Massias P, Gueguen J, France P. Idiopathic necrosis of the femoral head in adults. J Bone Joint Surg Br. 1965;47:612\u201333.","journal-title":"J Bone Joint Surg Br."},{"key":"1379_CR2","first-page":"73","volume":"277","author":"K Ohzono","year":"1992","unstructured":"Ohzono K, Saito M, Sugano N, Takaoka K, Ono K. The fate of nontraumatic avascular necrosis of the femoral head. A radiologic classification to formulate prognosis. Clin Orthop Relat Res. 1992;277:73\u20138.","journal-title":"Clin Orthop Relat Res."},{"key":"1379_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00003086-198912000-00022","volume":"249","author":"RK Aaron","year":"1989","unstructured":"Aaron RK, Lennox D, Bunce GE, Ebert T. The conservative treatment of osteonecrosis of the femoral head. A comparison of core decompression and pulsing electromagnetic fields. Clin Orthop Relat Res. 1989;249:209\u201318.","journal-title":"Clin Orthop Relat Res."},{"key":"1379_CR4","first-page":"169","volume":"49","author":"MA Mont","year":"2000","unstructured":"Mont MA, Jones LC, Sotereanos DG, Amstutz HC, Hungerford DS. Understanding and treating osteonecrosis of the femoral head. Instr Course Lect. 2000;49:169\u201385.","journal-title":"Instr Course Lect."},{"key":"1379_CR5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2106\/00004623-199503000-00018","volume":"77","author":"MA Mont","year":"1995","unstructured":"Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459\u201374.","journal-title":"J Bone Joint Surg Am."},{"key":"1379_CR6","first-page":"8","volume":"130","author":"JE Kenzora","year":"1978","unstructured":"Kenzora JE, Steele RE, Yosipovitch ZH, Glimcher MJ. Experimental osteonecrosis of the femoral head in adult rabbits. Clin Orthop Relat Res. 1978;130:8\u201346.","journal-title":"Clin Orthop Relat Res."},{"key":"1379_CR7","doi-asserted-by":"crossref","first-page":"e96361","DOI":"10.1371\/journal.pone.0096361","volume":"9","author":"C Wang","year":"2014","unstructured":"Wang C, Wang X, Xu XL, Yuan XL, Gou WL, Wang AY, Guo QY, Peng J, Lu SB. Bone microstructure and regional distribution of osteoblast and osteoclast activity in the osteonecrotic femoral head. PLoS One. 2014;9:e96361.","journal-title":"PLoS One."},{"key":"1379_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2739\/kurumemedj.47.37","volume":"47","author":"K Shibayama","year":"2000","unstructured":"Shibayama K. Idiopathic osteonecrosis of the femoral head in the elderly. Kurume Med J. 2000;47:37\u201343.","journal-title":"Kurume Med J."},{"key":"1379_CR9","first-page":"949","volume":"49","author":"S Agarwala","year":"2001","unstructured":"Agarwala S, Sule A, Pai BU, Joshi VR. Study of alendronate in avascular necrosis of bone. J Assoc Physicians India. 2001;49:949\u201350.","journal-title":"J Assoc Physicians India."},{"key":"1379_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.blo.0000194078.32776.31","volume":"443","author":"T Nishii","year":"2006","unstructured":"Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res. 2006;443:273\u20139.","journal-title":"Clin Orthop Relat Res."},{"key":"1379_CR11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1302\/0301-620X.91B8.21518","volume":"91","author":"S Agarwala","year":"2009","unstructured":"Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. J Bone Joint Surg Br. 2009;91:1013\u20138.","journal-title":"J Bone Joint Surg Br."},{"key":"1379_CR12","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/art.33498","volume":"64","author":"CH Chen","year":"2012","unstructured":"Chen CH, Chang JK, Lai KA, Hou SM, Chang CH, Wang GJ. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2012;64:1572\u20138.","journal-title":"Arthritis Rheum."},{"key":"1379_CR13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1073\/pnas.71.2.384","volume":"71","author":"HD Niall","year":"1974","unstructured":"Niall HD, Sauer RT, Jacobs JW, Keutmann HT, Segre GV, O'Riordan JL, Aurbach GD, Potts Jr JT. The amino-acid sequence of the amino-terminal 37 residues of human parathyroid hormone. Proc Natl Acad Sci U S A. 1974;71:384\u20138.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"1379_CR14","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/endo.138.11.5505","volume":"138","author":"H Dobnig","year":"1997","unstructured":"Dobnig H, Turner RT. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology. 1997;138:4607\u201312.","journal-title":"Endocrinology."},{"key":"1379_CR15","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1172\/JCI116483","volume":"91","author":"V Shen","year":"1993","unstructured":"Shen V, Dempster DW, Birchman R, Xu R, Lindsay R. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest. 1993;91:2479\u201387.","journal-title":"J Clin Invest."},{"key":"1379_CR16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/endo-129-1-421","volume":"129","author":"L Mosekilde","year":"1991","unstructured":"Mosekilde L, S\u00f8gaard CH, Danielsen CC, T\u00f8rring O. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). Endocrinology. 1991;129:421\u20138.","journal-title":"Endocrinology."},{"key":"1379_CR17","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","volume":"18","author":"Y Jiang","year":"2003","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 2003;18:1932\u201341.","journal-title":"J Bone Miner Res."},{"key":"1379_CR18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","volume":"65","author":"RP Harper","year":"2007","unstructured":"Harper RP, Fung E. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg. 2007;65:573\u201380.","journal-title":"J Oral Maxillofac Surg."},{"key":"1379_CR19","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3899\/jrheum.081176","volume":"36","author":"AN Lau","year":"2009","unstructured":"Lau AN, Adachi JD. Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol. 2009;36:1835\u20137.","journal-title":"J Rheumatol."},{"key":"1379_CR20","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hed.21380","volume":"33","author":"JJ Lee","year":"2011","unstructured":"Lee JJ, Cheng SJ, Jeng JH, Chiang CP, Lau HP, Kok SH. Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck. 2011;33:1366\u201371.","journal-title":"Head Neck."},{"key":"1379_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12891-015-0589-z","volume":"16","author":"Y Dong","year":"2015","unstructured":"Dong Y, Li Y, Huang C, Gao K, Weng X. Systemic application of teriparatide for steroid induced osteonecrosis in a rat model. BMC Musculoskelet Disord. 2015;16:163.","journal-title":"BMC Musculoskelet Disord."},{"key":"1379_CR22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s007760200108","volume":"7","author":"N Sugano","year":"2002","unstructured":"Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci. 2002;7:601\u20135.","journal-title":"J Orthop Sci."},{"key":"1379_CR23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bone.2010.05.022","volume":"47","author":"A Miyauchi","year":"2010","unstructured":"Miyauchi A, Matsumoto T, Sugimoto T, Tsujimoto M, Warner MR, Nakamura T. Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases. Bone. 2010;47:493\u2013502.","journal-title":"Bone."},{"key":"1379_CR24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00774-011-0314-4","volume":"30","author":"M Tsujimoto","year":"2012","unstructured":"Tsujimoto M, Uenaka K, Iwata A, Higashiuchi Y, Sowa H. Effects of teriparatide in Japanese and non-Japanese populations: bridging findings on pharmacokinetics and efficacy. J Bone Miner Metab. 2012;30:326\u201337.","journal-title":"J Bone Miner Metab."},{"issue":"5","key":"1379_CR25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00774-005-0616-5","volume":"23","author":"S Uchida","year":"2005","unstructured":"Uchida S, Taniguchi T, Shimizu T, Kakikawa T, Okuyama K, Okaniwa M, et al. Therapeutic effects of alendronate 35\u00a0mg once weekly and 5\u00a0mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study. J Bone Miner Metab. 2005;23(5):382\u20138.","journal-title":"J Bone Miner Metab"},{"key":"1379_CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00003086-200105000-00022","volume":"386","author":"JW Pritchett","year":"2001","unstructured":"Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001;386:173\u20138.","journal-title":"Clin Orthop Relat Res."},{"key":"1379_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.blo.0000157539.67567.03","volume":"435","author":"CJ Glueck","year":"2005","unstructured":"Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;435:164\u201370.","journal-title":"Clin Orthop Relat Res."},{"key":"1379_CR28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11999-008-0178-7","volume":"466","author":"Y Wang","year":"2008","unstructured":"Wang Y, Yin L, Li Y, Liu P, Cui Q. Preventive effects of puerarin on alcohol-induced osteonecrosis. Clin Orthop Relat Res. 2008;466:1059\u201367.","journal-title":"Clin Orthop Relat Res."},{"key":"1379_CR29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1302\/0301-620X.87B4.15658","volume":"87","author":"AC Disch","year":"2005","unstructured":"Disch AC, Matziolis G, Perka C. The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost. J Bone Joint Surg Br. 2005;87:560\u20134.","journal-title":"J Bone Joint Surg Br."},{"key":"1379_CR30","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2526","volume":"10","author":"M J\u00e4ger","year":"2008","unstructured":"J\u00e4ger M, Tillmann FP, Thornhill TS, Mahmoudi M, Blondin D, Hetzel GR, et al. Rationale for prostaglandin I2 in bone marrow oedema\u2014from theory to application. Arthritis Res Ther. 2008;10:R120.","journal-title":"Arthritis Res Ther."},{"key":"1379_CR31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2010.06.003","volume":"37","author":"J Green","year":"2010","unstructured":"Green J, Cl\u00e9zardin P. The molecular basis of bisphosphonate activity: a preclinical perspective. Semin Oncol. 2010;37:S3\u201311.","journal-title":"Semin Oncol."},{"key":"1379_CR32","first-page":"2155","volume":"87","author":"KA Lai","year":"2005","unstructured":"Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. 2005;87:2155\u20139.","journal-title":"J Bone Joint Surg Am"},{"key":"1379_CR33","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00296-013-2771-7","volume":"33","author":"PK Wong","year":"2013","unstructured":"Wong PK, Borromeo GL, Wark JD. Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease. Rheumatol Int. 2013;33:2189\u201398.","journal-title":"Rheumatol Int."},{"key":"1379_CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/iep.12007","volume":"94","author":"N Conte Neto","year":"2013","unstructured":"Conte Neto N, Spolidorio LC, Andrade CR, Bastos A S, Guimar\u00e3es M, Marcantonio Jr E. Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents. Int J Exp Pathol. 2013;94:65\u201373.","journal-title":"Int J Exp Pathol"},{"key":"1379_CR35","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.4317\/medoral.17946","volume":"17","author":"MS Bocanegra-P\u00e9rez","year":"2012","unstructured":"Bocanegra-P\u00e9rez MS, Vicente-Barrero M, Sosa-Henr\u00edquez M, Rodr\u00edguez-Bocanegra E, Limi\u00f1ana-Ca\u00f1al JM, L\u00f3pez-M\u00e1rquez A, et al. Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws. Med Oral Patol Oral Cir Bucal. 2012;17:e948\u201355.","journal-title":"Med Oral Patol Oral Cir Bucal."},{"key":"1379_CR36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJMc1403799","volume":"371","author":"J Schilcher","year":"2014","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Micha\u00eblsson K. Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med. 2014;371:974\u20136.","journal-title":"N Engl J Med."},{"issue":"8","key":"1379_CR37","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1302\/0301-620X.96B8.33306","volume":"96-B","author":"T Meling","year":"2014","unstructured":"Meling T, Nawab A, Harboe K, Fosse L. Atypical femoral fractures in elderly women: a fracture registry-based cohort study. Bone Joint J. 2014;96-B(8):1035\u201340.","journal-title":"Bone Joint J"},{"key":"1379_CR38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00590-016-1742-6","volume":"26","author":"L Blum","year":"2016","unstructured":"Blum L, Cummings K, Goulet JA, Perdue AM, Mauffrey C, Hake ME. Atypical femur fractures in patients receiving bisphosphonate therapy: etiology and management. Eur J Orthop Surg Traumatol. 2016;26:371\u20137.","journal-title":"Eur J Orthop Surg Traumatol."},{"key":"1379_CR39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","volume":"104","author":"RL Jilka","year":"1999","unstructured":"Jilka RL, Weinstein RS, Bellido T, et al. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999;104:439\u201346.","journal-title":"J Clin Invest."},{"key":"1379_CR40","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","volume":"16","author":"DW Dempster","year":"2001","unstructured":"Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res. 2001;16:1846\u201353.","journal-title":"J Bone Miner Res."},{"key":"1379_CR41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2106\/JBJS.G.01443","volume":"90","author":"GL Barnes","year":"2008","unstructured":"Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am. 2008;90:120\u20137.","journal-title":"J Bone Joint Surg Am."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T01:46:51Z","timestamp":1658454411000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1379-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1379-y","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]},"article-number":"24"}}